| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.06 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |